UDP-glucuronosyltransferase 1A4 (UGT1A4) polymorphisms in a Jordanian population

被引:14
作者
Hakooz, Nancy [1 ,2 ]
Alzubiedi, Sameh [2 ]
Yousef, Al-Motassem [2 ]
Arafat, Tawfiq [3 ]
Dajani, Rana [4 ]
Ababneh, Nidaa [5 ]
Ismail, Said [5 ]
机构
[1] Zarqa Univ, Fac Pharm, Zarqa 13132, Jordan
[2] Univ Jordan, Fac Pharm, Amman 11942, Jordan
[3] Jordan Ctr Pharmaceut Res, Amman 11195, Jordan
[4] Hashemite Univ, Dept Biol, Zarqa 13115, Jordan
[5] Univ Jordan, Fac Med, Amman 11942, Jordan
关键词
Drug metabolism; UGT1A4; Jordanian population; Polymorphism; CYP1A2 GENETIC POLYMORPHISMS; HUMAN LIVER-MICROSOMES; JAPANESE POPULATION; LEBANESE POPULATION; GLUCURONIDATION; PHARMACOGENETICS; TAMOXIFEN; PREVALENCE; TACROLIMUS; HAPLOTYPES;
D O I
10.1007/s11033-012-1615-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glucuronidation is one of the most important phase II metabolic pathways. It is catalyzed by a family of UDP-glucuronosyltransferase enzymes (UGTs). One of the subfamilies is UGT1A. Allele frequencies in UGT1A4 differ among ethnic groups. The aim of this study was to determine the allelic frequency of two most common defective alleles: UGT1A4*2 and UGT1A4*3 in a Jordanian population. A total of 216 healthy Jordanian Volunteers (165 males and 51 females) were included in this study. Genotyping for UGT1A4*1, UGT1A4*2 and UGT1A4*3 was done using a well established polymerase chain reaction-restriction fragment length polymorphism test. Among 216 random individuals studied for UGT1A4*2 mutation there were 26 individuals who were heterozygous, giving a prevalence of 12% and an allele frequency of 6.5%. Only one individual was homozygous for UGT1A4*2. The UGT1A4*3 mutation was detected as heterozygous in 9 of 216 individuals indicating a prevalence of 4.2% and allele frequency of 3.5%. Three individuals were homozygous for the UGT1A4*3 indicating a prevalence of 1.4%. The prevalence of UGT1A4*2 is similar to the Caucasians but different from other populations whilst the UGT1A4*3 prevalence in the Jordanian population is distinct from other populations. Our results provide useful information for the Jordanian population and for future genotyping of Arab populations in general.
引用
收藏
页码:7763 / 7768
页数:6
相关论文
共 50 条
  • [41] Irinotecan decreases intestinal UDP-glucuronosyltransferase (UGT) 1A1 via TLR4/MyD88 pathway prior to the onset of diarrhea
    Tao, Gabriel
    Dagher, Fatima
    Li, Li
    Singh, Rashim
    Hu, Ming
    Ghose, Romi
    FOOD AND CHEMICAL TOXICOLOGY, 2022, 166
  • [42] Backbone assignment of the apo-form of the human C-terminal domain of UDP-glucuronosyltransferase 1A (UGT1A)
    Osborne, Michael J.
    de Oliveira, Luciana Coutinho
    Volpon, Laurent
    Borden, Katherine L. B.
    BIOMOLECULAR NMR ASSIGNMENTS, 2018, 12 (02) : 315 - 318
  • [43] Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications
    Ciotti, M
    Marrone, A
    Potter, C
    Owens, IS
    PHARMACOGENETICS, 1997, 7 (06): : 485 - 495
  • [44] Renal Cell Carcinoma Treatment Drug Everolimus Inhibited UDP-Glucuronosyltransferase (UGT) 1A6
    Zhang, Xue-Feng
    Chen, Yun
    Wang, Jiang-Jun
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (07): : 1284 - 1288
  • [45] Potential Role of UGT1A4 Promoter SNPs in Anastrozole Pharmacogenomics
    Edavana, Vineetha Koroth
    Dhakal, Ishwori B.
    Williams, Suzanne
    Penney, Rosalind
    Boysen, Gunnar
    Yao-Borengasser, Aiwei
    Kadlubar, Susan
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (04) : 870 - 877
  • [46] The effects of UGT1A4 and ABCB1 polymorphisms on clozapine and Ndesmethyl clozapine plasma levels in Turkish schizophrenia patients
    Ozdemir, Fezile
    Oz, Merve Demirbugen
    Tok, Kenan Can
    Dural, Emrah
    Kir, Yagmur
    Gumustas, Mehmet
    Baskak, Bora
    Suzen, H. Sinan
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2025, 495
  • [47] Cabozantinib Carries the Risk of Drug-Drug Interactions via Inhibition of UDP-glucuronosyltransferase (UGT) 1A9
    Wang, Zhe
    Jiang, Lili
    Wang, Xiaoyu
    Yin, Hang
    Wang, Zhen
    Lv, Xin
    Liu, Yong
    CURRENT DRUG METABOLISM, 2022, 23 (11) : 912 - 919
  • [48] Isolation and characterization of a UDP-glucuronosyltransferase (UGT1A01) cloned from female rhesus monkey
    Dean, B
    Chang, S
    Stevens, J
    Thomas, PE
    King, C
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 402 (02) : 289 - 295
  • [49] Characterization of UDP-glucuronosyltransferase 2A1 (UGT2A1) variants and their potential role in tobacco carcinogenesis
    Bushey, Ryan T.
    Chen, Gang
    Blevins-Primeau, Andrea S.
    Krzeminski, Jacek
    Amin, Shantu
    Lazarus, Philip
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (02) : 55 - 65
  • [50] Comparison of the Inhibition Capability of Baicalin and Baicalein towards Intestinal UDP-Glucuronosyltransferase (UGT) 1A10
    Gong, Hong-Yan
    Cheng, Wei-Cai
    Wang, Yong
    Wan, Yong
    Niu, Jun
    LATIN AMERICAN JOURNAL OF PHARMACY, 2013, 32 (04): : 610 - 612